Researchers - Kenneth Rainin Foundation

Researchers

Supporting new and seasoned investigators alike and embracing untested ideas gives us the best chance of discovering breakthroughs in Inflammatory Bowel Disease research. Get to know our Health Program grantees.

Gregory Fairn, PhD, Professor, Dalhousie University

Gregory Fairn, PhD

Professor, Dalhousie University, Former Grantee

The Fairn lab studies a variety of aspects related to vesicular and non-vesicular transport of lipids, lipid metabolism, membrane dynamics and the cell biology of immune cells.
Headshot of Jeremiah Faith

Jeremiah Faith, PhD

Associate Professor, Icahn School Of Medicine At Mount Sinai, Former Grantee

The Faith lab is developing and applying experimental and computational tools to understand gut microbiota structure and function to develop live defined microbial therapeutics.
Kate Fitzgerald, Professor, University of Massachusetts

Kate Fitzgerald, PhD

Professor, University of Massachusetts, Current Grantee

The Fitzgerald lab investigates the molecular mechanism controlling the innate immune response during infection and inflammation. They focus on therapeutic targeting of Inflammasomes and nucleic acid sensing pathways to treat inflammatory diseases.
Yaron Fuchs Headshot

Yaron Fuchs, PhD

Assistant Professor, Technion – Israel Institute of Technology, Former Grantee

The Fuchs lab seeks to understand how stem cells use the apoptotic machinery for their elimination and the effect this has on different aspects of stem cell biology and stem cell-dependent processes.
Headshot of Wendy Garrett, MD, PhD.

Wendy Garrett, MD, PhD

Professor, Harvard University, Current Grantee

The Garrett lab focuses on mucosal immunology and the gut microbiota. They study intestinal inflammation in colitis and the tumor microenviroment in colorectal cancer, with a specific focus on the gut microbiota and immune system.
Klaus Gerwert, Professor, Ruhr University Bochum

Klaus Gerwert, PhD

Professor, Ruhr University Bochum, Former Grantee

Dr. Gerwert works in the field of protein science, aiming to detect neurodegenerative diseases at an early stage to prevent progression to symptomatic conditions.